Pentoxifylline alters class-specific immunoglobulin synthesis in resuscitated burn injury.
Pentoxifylline (PTXF) is a hemorheologic agent that can attenuate microvascular alterations induced by injury, resulting in improved microcirculatory flow. Burn injury-induced immunologic suppression may be caused by alterations in microvascular flow. We studied the effects of PTXF on humoral immunity in resuscitated burn injury. Male AKR mice (n = 80) were randomized to four groups: SHAM, BURN, PTXF-BURN, and NS-BURN (saline burn). Animals were resuscitated with Ringer's lactate and morphine sulfate and put to death at days 1 and 4 after injury. PTXF-BURN animals received PTXF (50 mg/kg intraperitoneally) at the time of resuscitation. Splenic lymphocytes (1 x 10(6) cells/well) were cultured with lipopolysaccharide (LPS) (2.5 and 10 micrograms/ml)). LPS-stimulated in vitro class-specific immunoglobulin (Ig) production was determined by enzyme-linked immunosorbent assay from splenic cell culture supernatants. Burn injury induced a reduction in immunoglobulin (Ig) M synthesis on postburn day 4. PTXF treatment was associated with an increase in IgG production, but a greater depression in IgM synthesis than burn injury alone. PTXF administration during resuscitation in burn injury does not ameliorate the burn-induced depression in IgM synthesis and results in significant potential adverse modulation of humoral immune function.